Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryanne Senna

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Dermatology and Therapy|April 16, 2026
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based ApproachBrett King, Maryanne Senna, Manabu Ohyama, et al.
Journal of the American Academy of Dermatology|October 24, 2024
Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2Brett King, Manabu Ohyama, Maryanne Senna, et al.
Journal of Cosmetic Dermatology|November 22, 2024
Revealing the Therapeutic Potential: Investigating the Impact of a Novel Witch Hazel Formula on Anti-Inflammation and AntioxidationXue Liu, Tamer-Whittle Hage, Li-Chi Chen, et al.
American Journal of Clinical Dermatology|March 31, 2026
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical StudiesMaryanne Senna, Jennifer Soung, Ignasi Figueras, et al.
Journal of the American Academy of Dermatology|October 18, 2024
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trialMelissa Piliang, Charles Lynde, Brett King, et al.
International Journal of Women'S Dermatology|February 16, 2026
Assessing workload, compensation, and burnout in academic dermatology: a national multi-institutional survey studyAnna L Brinks, Carli Needle Lawrence, Caitlin A Kearney, et al.
Journal of the American Academy of Dermatology|February 10, 2024
Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendationsTiaranesha Jackson, Yacine Sow, Jewell Dinkins, et al.
JAMA Dermatology|February 7, 2024
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity, Anthony Moussa, Michaela Bennett, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Dermatology and Therapy|April 16, 2026
How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based ApproachBrett King, Maryanne Senna, Manabu Ohyama, et al.
Journal of the American Academy of Dermatology|October 24, 2024
Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2Brett King, Manabu Ohyama, Maryanne Senna, et al.
Journal of Cosmetic Dermatology|November 22, 2024
Revealing the Therapeutic Potential: Investigating the Impact of a Novel Witch Hazel Formula on Anti-Inflammation and AntioxidationXue Liu, Tamer-Whittle Hage, Li-Chi Chen, et al.
American Journal of Clinical Dermatology|March 31, 2026
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical StudiesMaryanne Senna, Jennifer Soung, Ignasi Figueras, et al.
Journal of the American Academy of Dermatology|October 18, 2024
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trialMelissa Piliang, Charles Lynde, Brett King, et al.
International Journal of Women'S Dermatology|February 16, 2026
Assessing workload, compensation, and burnout in academic dermatology: a national multi-institutional survey studyAnna L Brinks, Carli Needle Lawrence, Caitlin A Kearney, et al.
Journal of the American Academy of Dermatology|February 10, 2024
Treatment for central centrifugal cicatricial alopecia-Delphi consensus recommendationsTiaranesha Jackson, Yacine Sow, Jewell Dinkins, et al.
JAMA Dermatology|February 7, 2024
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity, Anthony Moussa, Michaela Bennett, et al.
Pageof 2